Intersectional stigmas in cancer care can exacerbate disparities by compounding the challenges faced by individuals who belong to multiple marginalized groups, leading to inequities in access, treatment, and outcomes. There is often a lack of consistent implementation of screening and support services that address the unique needs of marginalized patients, resulting in disparities in early detection, treatment, and follow-up care.